ES2038532B1 - Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol. - Google Patents

Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.

Info

Publication number
ES2038532B1
ES2038532B1 ES9101147A ES9101147A ES2038532B1 ES 2038532 B1 ES2038532 B1 ES 2038532B1 ES 9101147 A ES9101147 A ES 9101147A ES 9101147 A ES9101147 A ES 9101147A ES 2038532 B1 ES2038532 B1 ES 2038532B1
Authority
ES
Spain
Prior art keywords
piperacinilbecimidazole
procedure
preparation
group
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9101147A
Other languages
English (en)
Other versions
ES2038532A1 (es
Inventor
Aurelio Orjales-Venero
Neftali Garcia-Dominguez
Victor Rubio-Royo
Rosa Rodes-Solanes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Original Assignee
Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA filed Critical Fabrica Espanola de Productos Quimicos y Farmaceuticos FAES SA
Priority to ES9101147A priority Critical patent/ES2038532B1/es
Priority to PT97882A priority patent/PT97882B/pt
Priority to AU15970/92A priority patent/AU666477B2/en
Priority to ZA923319A priority patent/ZA923319B/xx
Priority to KR1019920007702A priority patent/KR100227458B1/ko
Priority to AT92500056T priority patent/ATE183741T1/de
Priority to CA002068292A priority patent/CA2068292A1/en
Priority to EP92500056A priority patent/EP0512939B1/en
Priority to DE69229845T priority patent/DE69229845T2/de
Priority to DK92500056T priority patent/DK0512939T3/da
Priority to MX9202178A priority patent/MX9202178A/es
Priority to JP4144877A priority patent/JPH072795A/ja
Priority to TW081104137A priority patent/TW200478B/zh
Priority to US07/946,012 priority patent/US5256665A/en
Publication of ES2038532A1 publication Critical patent/ES2038532A1/es
Application granted granted Critical
Publication of ES2038532B1 publication Critical patent/ES2038532B1/es
Priority to GR990403022T priority patent/GR3031930T3/el
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE NUEVOS DERIVADOS DE 2-PIPERACINILBENCIMIDAZOL. SE DESCRIBE LA PREPARACION DE NUEVOS DERIVADOS DE 2-PIPERACINILBENCIMIDAZOL, DE FORMULA GENERAL FORMULA EN DONDE R PUEDE SER UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO DE CADENA CORTA, Y UN RADICAL FENILO SUSTITUIDO O NO EN LA POSICION CUATRO POR UN HALOGENO, Y RSI1 PUEDE SER UN ATOMO DE HIDROGENO, UN RADICAL ALCOXICARBONILO, UN GRUPO HIDROXIMETILO, Y UN GRUPO DIFENILMETILO, ASI COMO SUS SALES DE ADICION CON ACIDOS FARMACEUTICAMENTE ACEPTABLES. ESTOS COMPUESTOS PRESENTAN ACTIVIDAD FARMACOLOGICA COMO ANTAGONISTAS DE LOS RECEPTORES 5HTSI3 LA SEROTONINA.
ES9101147A 1991-05-10 1991-05-10 Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol. Expired - Fee Related ES2038532B1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES9101147A ES2038532B1 (es) 1991-05-10 1991-05-10 Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.
PT97882A PT97882B (pt) 1991-05-10 1991-06-06 Processo de preparacao de novos derivados de 2-piperazinilbenzimidazol
AU15970/92A AU666477B2 (en) 1991-05-10 1992-05-01 2-piperazinylbenzimidazole derivatives and processes for the preparation thereof
KR1019920007702A KR100227458B1 (ko) 1991-05-10 1992-05-07 신규 2-피페라지닐벤즈이미다졸 유도체
ZA923319A ZA923319B (en) 1991-05-10 1992-05-07 A process for preparing new 2-piperazinylbenzimidazole derivatives
DE69229845T DE69229845T2 (de) 1991-05-10 1992-05-08 2-Piperazinylbenzimidazolderivate
CA002068292A CA2068292A1 (en) 1991-05-10 1992-05-08 New 2-piperazinylbenzimidazole derivatives
EP92500056A EP0512939B1 (en) 1991-05-10 1992-05-08 2-piperazinylbenzimidazole derivatives
AT92500056T ATE183741T1 (de) 1991-05-10 1992-05-08 2-piperazinylbenzimidazolderivate
DK92500056T DK0512939T3 (da) 1991-05-10 1992-05-08 2-Piperazinylbenzimidazolderivater
MX9202178A MX9202178A (es) 1991-05-10 1992-05-11 Nuevos derivados de 2-piperacinil bencimidazol.
JP4144877A JPH072795A (ja) 1991-05-10 1992-05-11 新規な２−ピペラジニルベンズイミダゾール誘導体
TW081104137A TW200478B (es) 1991-05-10 1992-05-27
US07/946,012 US5256665A (en) 1991-05-10 1992-09-15 Process for preparing new 2-piperazinylbenzimidazole
GR990403022T GR3031930T3 (en) 1991-05-10 1999-11-24 New 2-piperazinylbenzimidazole derivatives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9101147A ES2038532B1 (es) 1991-05-10 1991-05-10 Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.

Publications (2)

Publication Number Publication Date
ES2038532A1 ES2038532A1 (es) 1993-07-16
ES2038532B1 true ES2038532B1 (es) 1994-02-16

Family

ID=8272328

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9101147A Expired - Fee Related ES2038532B1 (es) 1991-05-10 1991-05-10 Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.

Country Status (14)

Country Link
EP (1) EP0512939B1 (es)
JP (1) JPH072795A (es)
KR (1) KR100227458B1 (es)
AT (1) ATE183741T1 (es)
AU (1) AU666477B2 (es)
CA (1) CA2068292A1 (es)
DE (1) DE69229845T2 (es)
DK (1) DK0512939T3 (es)
ES (1) ES2038532B1 (es)
GR (1) GR3031930T3 (es)
MX (1) MX9202178A (es)
PT (1) PT97882B (es)
TW (1) TW200478B (es)
ZA (1) ZA923319B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201744B (es) * 1991-07-02 1993-03-11 Kanebou Textile Co Ltd
JP3193560B2 (ja) * 1993-04-16 2001-07-30 明治製菓株式会社 新規ベンゾオキサゾール誘導体
ES2072193B1 (es) * 1993-05-21 1996-02-16 Espanola Prod Quimicos Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
FR2731707B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JP3520177B2 (ja) * 1996-05-09 2004-04-19 明治製菓株式会社 セロトニン５−ｈｔ３受容体部分活性薬
CA2671857C (en) * 2007-01-25 2013-11-19 Janssen Pharmaceutica Nv 2-piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
AU7997091A (en) * 1990-05-30 1991-12-31 American Home Products Corporation Substituted arylsulfonamides and benzamides

Also Published As

Publication number Publication date
KR100227458B1 (ko) 1999-11-01
DE69229845D1 (de) 1999-09-30
DE69229845T2 (de) 2000-04-27
PT97882B (pt) 1998-10-30
CA2068292A1 (en) 1992-11-11
ATE183741T1 (de) 1999-09-15
GR3031930T3 (en) 2000-03-31
AU666477B2 (en) 1996-02-15
MX9202178A (es) 1992-11-01
ES2038532A1 (es) 1993-07-16
JPH072795A (ja) 1995-01-06
TW200478B (es) 1993-02-21
DK0512939T3 (da) 2000-03-13
EP0512939A1 (en) 1992-11-11
AU1597092A (en) 1992-11-12
ZA923319B (en) 1994-02-07
PT97882A (pt) 1993-04-30
KR920021527A (ko) 1992-12-18
EP0512939B1 (en) 1999-08-25

Similar Documents

Publication Publication Date Title
DE69027235D1 (de) Xanthinderivate
ES2060655T3 (es) Derivados de lactamas.
NO900487D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzimidazolderivater.
ATE143661T1 (de) Imidazonaphthyridinderivate
ES2038532B1 (es) Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.
ES2115608T3 (es) Procedimiento para preparar derivados lactamicos.
DE3880022T2 (de) Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen.
ATE78254T1 (de) Indol-derivate.
ES2072193B1 (es) Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
FI891807A (fi) Menetelmä terapeuttisesti aktiivisten oktahydropyrrolo-pyratsino/2,1-i/indol-2-oni-johdannaisten valmistamiseksi
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
PT99250A (pt) Processo para a preparacao de derivados de piperazina
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040511